This site is intended for healthcare professionals only
LoginRegister
Pfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual MigrainePfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine
Aurobindo Pharma recallSafety first: Aurobindo recalls discolored pain relieving drug in US
USFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapiesUSFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies
Granules Pharma USA facility USFDA inspectionUSFDA issues 1 observation for Granules Pharma USA facility
15 Drugs Including Pomol-650, Glimiz-2 Banned in Karnataka, Check Full List14 Drugs Including Pomol-650, Glimiz-2 Banned in Karnataka, Check Full List
Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III ProtocolAkums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III...
CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine TrialCDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial
Two arrested over counterfeit version of Sun Pharma drugs seized in HyderabadTwo arrested over counterfeit version of Sun Pharma drugs seized in Hyderabad
Sun Pharma ropes in Richard Ascroft as North America CEOSun Pharma ropes in Richard Ascroft as North America CEO
Biocon Biologics Yesafili gets Health Canada nod for eye diseasesBiocon Biologics Yesafili gets Health Canada nod for eye diseases
Health Ministry Plans Licence Suspension for Drugs Failing Quality Standards: ReportHealth Ministry Plans Licence Suspension for Drugs Failing Quality Standards: Report
Bharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITPBharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITP
X